CN104367912A - 一种预防及治疗糖尿病的中药及其片剂的制备方法 - Google Patents
一种预防及治疗糖尿病的中药及其片剂的制备方法 Download PDFInfo
- Publication number
- CN104367912A CN104367912A CN201410583041.8A CN201410583041A CN104367912A CN 104367912 A CN104367912 A CN 104367912A CN 201410583041 A CN201410583041 A CN 201410583041A CN 104367912 A CN104367912 A CN 104367912A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- traditional chinese
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 6
- 239000007779 soft material Substances 0.000 claims abstract description 6
- 229960004793 sucrose Drugs 0.000 claims abstract description 6
- 230000002265 prevention Effects 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 238000001256 steam distillation Methods 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 35
- 210000002700 urine Anatomy 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 241000572565 Alpinia oxyphylla Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000004821 distillation Methods 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 24
- 239000008103 glucose Substances 0.000 description 24
- 210000004072 lung Anatomy 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 239000003472 antidiabetic agent Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940127003 anti-diabetic drug Drugs 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000004923 pancreatic tissue Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中药片剂,具体涉及一种预防及治疗糖尿病的中药及其片剂的制备方法。中药片剂按照重量份数计,由以下中药原料配制:生地10-15份,葛根8-10份,黄连8-10份,麦冬4-8份,人参10-15份,牛膝5-8份,知母5-8份,山栀子5-8份,怀山药10-15份,牡丹皮6-8份,泽泻6-8份,茯苓8-10份,益智仁10-15份,炙甘草10-15份,五味子10-15份。制备方法步骤如下:将除人参和怀山药之外的其他原料放入蒸馏瓶中,用水蒸气蒸馏法提取其有效成分,将人参和怀山药粉碎成细粉后,与蔗糖粉混合放入提取液中,搅拌均匀制成软材,过10-20目筛得到颗粒,将颗粒加入硬脂酸镁润滑剂后,放入压片机压片,得到每片0.15-0.18g的片剂即可。优点:不仅血糖、尿糖得到有效控制,精力、体力等功能也恢复到正常水平。
Description
技术领域
本发明涉及一种中药片剂,具体涉及一种预防及治疗糖尿病的中药及其片剂的制备方法。
背景技术
目前全球糖尿病患者为2.85亿,我国糖尿病患者约9240万,糖尿病前期患者1.48亿,糖尿病已成为导致全球人口死亡的第四大疾病。鉴于糖尿病给人类带来的巨大危害,世界卫生组织称之为“21世纪的灾难”。糖尿病的病程长,治疗费用昂贵,据中华医学会糖尿病学分会统计,中国糖尿病的直接医疗开支达到1734亿元,占全国医疗总开支的13%。不仅影响了患者的生活和生命质量,也给国家和人民带来了沉重的经济负担,因此开发新型抗糖尿病药物或具有辅助降血糖功能的保健食品具有广泛的经济、社会效益。
在治疗糖尿病历史上有过两次重大突破:第一次是20世纪50年代,中国首次人工合成胰岛素,震惊世界;第二次是双胍类及磺脲类口服降糖药的问世,使糖尿病患者的血糖得以暂时控制。目前用于临床治疗所用中西药已达数十种,但是由于对糖尿病病理、病因研究至今还没有实质性的突破,治疗糖尿病仍处于控制血糖、尿糖增高阶段和预防综合并发症的研究阶段。此外,患者长期服用西药,会对肾、肝、心、脾、胃等脏器带来副作用。国内新开发出来的各种药剂无法对人体胰腺组织损伤有修复作用,而无法从根本上预防及治疗糖尿病。
发明内容
根据以上现有技术的不足,力图从养生保健的角度,提供一种滋肾温阳、活血化淤,有效减轻和控制糖尿病并发症的预防及治疗糖尿病的中药及其片剂的制备方法。
本发明所述的一种治疗糖尿病的中药片剂,按照重量份数计,由以下中药原料配制:生地10-15份,葛根8-10份,黄连8-10份,麦冬4-8份,人参10-15份,牛膝5-8份,知母5-8份,山栀子5-8份,怀山药10-15份,牡丹皮6-8份,泽泻6-8份,茯苓8-10份,益智仁10-15份,炙甘草10-15份,五味子10-15份。
一种治疗糖尿病的中药片剂,按照重量份数计,优选由以下中药原料配制而成:生地12份,葛根9份,黄连9份,麦冬5份,人参12份,牛膝7份,知母6份,山栀子7份,怀山药12份,牡丹皮7份,泽泻7份,茯苓9份,益智仁13份,炙甘草13份,五味子13份。
一种权利要求1所述的预防及治疗糖尿病的中药片剂的制备方法,步骤如下:将除人参和怀山药之外的其他原料放入蒸馏瓶中,用水蒸气蒸馏法提取其有效成分,将人参和怀山药粉碎成细粉后,与蔗糖粉混合放入提取液中,搅拌均匀制成软材,过10-20目筛得到颗粒,将颗粒加入硬脂酸镁润滑剂后,放入压片机压片,得到每片0.15-0.18g的片剂即可。
药理分析:
生地:清热生津,凉后,止血;用于热风伤阴、舌绛烦渴、发斑发疹、吐血、衄血、咽喉肿痛。生地黄清热凉血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。
葛根:能够活血化瘀、宁心安神、平肝潜阳,有改善心脑循环,增加脑血流量和降低血压的作用。
黄连:黄连它本身的主要成份是黄连素,主治清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。
麦冬:性微甘味苦,寒;甘微苦寒;入肺胃心经;养阴生津,润肺清心;用于肺燥干咳,心烦失眠,内热消渴。
人参:有良好的抗衰老、抗疲劳、提高人体的免疫力、调节神经系统和兴奋造血系统功能等作用。改善中老年人的微循环,提高记忆、学习能力。常用于治疗各种类型的老年痴呆,尤其适用于心脾气血两虚症,或兼肺气亏虚、神疲乏力、虚咳喘促、自汗暴脱等症。发热感冒、咳嗽痰多、心肝火旺、湿热蕴阻、食滞不化者慎用。
牛膝:味苦;酸;性平。腰膝酸痛;下肢痿软;血滞经闭;痛经;产后血瘀腹痛;症瘕;胞衣不下;热淋;血淋;跌打损伤;痈肿恶疮;咽喉肿痛。
知母:具有活血、利尿、通经、滋阳、润燥、调血脂、通九窍、利关节、养气血等功能,主治腹痛、水肿、产后瘀血、跌打损伤等症。
山栀子:主治热病心烦、肝火目赤、头痛、湿热黄疳、淋证、血痢尿血、口舌生疮、疮疡肿毒、扭伤肿痛。
怀山药:健脾益胃、助消化:山药含有淀粉酶、多酚氧化酶等物质,有利于脾胃消化吸收功能,是一味平补脾胃的药食两用之品。不论脾阳亏或胃阴虚,皆可食用。临床上常用治脾胃虚弱、食少体倦、泄泻等病症;滋肾益精:山药含有多种营养素,有强健机体,滋肾益精的作用。大凡肾亏遗精,妇女白带多、小便频数等症,皆可服之;益肺止咳:山药含有皂甙、黏液质,有润滑,滋润的作用,故可益肺气,养肺阴,治疗肺虚痰嗽久咳之症;降低血糖:山药含有粘液蛋白,有降低血糖的作用,可用于治疗糖尿病,是糖尿病人的食疗佳品。
牡丹皮:性寒,味苦;凉;微寒。归心;肝;肾;肺经。味苦、辛,微寒。归心、肝、肾经。清热凉血;活血散瘀。温热病热入血分;发斑;吐衄;热病后期热伏阴分发热;阴虚骨蒸潮热;血滞经闭;痛经;痈肿疮毒;跌扑伤痛;风湿热痹。
泽泻:利水,渗湿,泄热。治小便不利,水肿胀满,呕吐,泻痢,痰饮,脚气,淋病,尿血。
茯苓:具有抗氧化,防衰老,增加免疫力,提高大脑细胞活性的作用。茯苓有较强的利尿作用,可治疗肾炎、心衰水肿。另外还有镇静作用,对神经衰弱有效。味淡性平,善益气养血,宁心安神,败毒抗癌;药性平和,利湿而不伤正气,所含茯苓酸具有增强免疫力、抗肿瘤以及镇静、降血糖等的作用;可松弛消化道平滑肌,抑制胃酸分泌,防止肝细胞坏死,抗菌等功效。
益智仁:温脾止泻摄唾,暖肾固精缩尿。用于脾寒泄泻,腹中冷痛,口多唾涎,肾虚遗尿,小便频数,遗精白浊。
炙甘草:具有益气滋阴,通阳复脉治疗功效;和中缓急,润肺,解毒,调和诸药;常用于脾胃虚弱,倦怠乏力,心动悸,脉结代,可解附子毒。
五味子:治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢。能增强中枢神经系统的兴奋过程,也能加强抑制过程,使其相互平衡,提高大脑皮层的调节作用;能提高工作率,减轻疲劳。能调节血压,增强心脏功能。能兴奋呼吸,并有祛痰、镇咳作用。能促进胆汁分泌、降低肝炎病人血清谷-丙转氨酶,对肝细胞有一定保护作用。能增强机体对非特异性刺激的防御能力。用于气虚津伤,体倦多汗,短气心悸;肺气不足或肺肾两虚所致的喘咳,或喘咳日久,肺气耗伤;心阴不足,心悸怔忡,失眠健忘;肾气不固,遗精,尿频,或脾肾两虚,久泻不止。
本发明的优点在于所使用的中药符合中华人民共和国药典规定,药物安全可靠,具有益气养阴,生津清热,降低血糖的功效,服用后,不仅血糖、尿糖得到有效控制,精力、体力等功能也能恢复正常,且糖化血清蛋白有明显下降,对胰腺组织损伤也有一定的修复作用。
疗效评定:
显效:治疗后症状基本消失,空腹血糖<7.2mmol/L(130mg/dl),餐后2小时血糖<8.3mmol/L(150mg/dl),24小时尿糖定量<10.0g,或血糖、24小时尿糖定量较治疗前下降30%以上。
有效:治疗后症状明显改善,空腹血糖<8.3mmol/L(150mg/dl),餐后2小时血糖<10.0mmol/L(180mg/dl),24小时尿糖定量<25.0g,或血糖、24小时尿糖定量较治疗前下降10%以上。
无效:治疗后症状无明显改善,血糖、尿糖下降未达到上述标准。
以下列举几个典型病例:
病例1:
刘某某,男,40岁,工作压力较大,作息不规律,养成了很不好的饮食习惯,不久前查出患有糖尿病,血糖时常不稳定,之前通过西药治疗,副作用大,精神状态不佳,选择了本发明的中药的治疗方法,半个月后,病情得到明显好转,在持续服用2个多月后,血糖已经稳定,病情得到康复,继续坚持服用了3个疗程,现已恢复正常生活。
病例2:
孙某某,男,55岁,患有糖尿病已经5年,血糖一直不稳,且伴随着血压不正常,为了解决这个问题,刘老先生吃各类降糖药,并注射过胰岛素,但是血糖仍然降不下去,后来,服用了本发明中药,在持续服用了2个疗程后,病情得到了控制,现在孙先生每天都在坚持记录血糖值,已经较平稳,并且精神状态很好,对生活又重拾信心了。
病例3:
赵某某,女,60岁,患有糖尿病已经10年,也持续治疗了很多年,主要是以吃降糖药和注射胰岛素为主,虽然经过一段时间,血糖能够得到一定降低,但是再隔一段时间后,血糖仍然会再次升高,复发率高,且注射治疗不但需要别人帮忙,而且自己也十分痛苦。并且降糖药和胰岛素的用量越来越大,否则血糖就降不下去,身体虚弱的同时承受着莫大的痛苦。在朋友的推荐下服用本发明,医生了解情况后,决定给予增加其用药剂量,在持续服用了1个月后,药性作用开始明显,在服用2个月后,病情明显减轻,而且血糖的含量一直稳定下降,现其仍然在服用,赵某某对最终战胜病魔很有信心。
具体实施方式
以下结合实施例对本发明做进一步说明,但本发明并不局限于具体的实施例。
实施例1:
一种预防及治疗糖尿病的中药片剂,按照重量份数计,由以下中药原料配制:生地15份,葛根8份,黄连10份,麦冬4份,人参15份,牛膝5份,知母8份,山栀子5份,怀山药15份,牡丹皮6份,泽泻8份,茯苓8份,益智仁15份,炙甘草10份,五味子15份。
实施例2:
一种预防及治疗糖尿病的中药片剂,按照重量份数计,由以下中药原料配制:生地10份,葛根10份,黄连8份,麦冬8份,人参10份,牛膝8份,知母5份,山栀子8份,怀山药10份,牡丹皮8份,泽泻6份,茯苓10份,益智仁10份,炙甘草15份,五味子10份。
实施例3:
一种预防及治疗糖尿病的中药片剂,按照重量份数计,由以下中药原料配制:生地12份,葛根9份,黄连9份,麦冬5份,人参12份,牛膝7份,知母6份,山栀子7份,怀山药12份,牡丹皮7份,泽泻7份,茯苓9份,益智仁13份,炙甘草13份,五味子13份。
实施例4:
一种预防及治疗糖尿病的中药片剂的制备方法,步骤如下:按实施例1的比例选取药物各组分,将除人参和怀山药之外的其他原料放入蒸馏瓶中,用水蒸气蒸馏法提取其有效成分,将人参和怀山药粉碎成细粉后,与蔗糖粉混合放入提取液中,搅拌均匀制成软材,过10-20目筛得到颗粒,将颗粒加入硬脂酸镁润滑剂后,放入压片机压片,得到每片0.15-0.18g的片剂即可。
实施例5:
一种预防及治疗糖尿病的中药片剂的制备方法,步骤如下:按实施例2的比例选取药物各组分,将除人参和怀山药之外的其他原料放入蒸馏瓶中,用水蒸气蒸馏法提取其有效成分,将人参和怀山药粉碎成细粉后,与蔗糖粉混合放入提取液中,搅拌均匀制成软材,过10-20目筛得到颗粒,将颗粒加入硬脂酸镁润滑剂后,放入压片机压片,得到每片0.15-0.18g的片剂即可。
实施例6:
一种预防及治疗糖尿病的中药片剂的制备方法,步骤如下:按实施例3的比例选取药物各组分,将除人参和怀山药之外的其他原料放入蒸馏瓶中,用水蒸气蒸馏法提取其有效成分,将人参和怀山药粉碎成细粉后,与蔗糖粉混合放入提取液中,搅拌均匀制成软材,过10-20目筛得到颗粒,将颗粒加入硬脂酸镁润滑剂后,放入压片机压片,得到每片0.15-0.18g的片剂即可。
综上:
收集120例门诊糖尿病患者,男60例,女60例;年龄40-65岁,平均53岁;随机分为西药组(服用甲钴胺片)、实施例1、实施例2、实施例3,每组30例;各组患者年龄症状构成无显著差异;治疗组患者服用本发明中实施例1、实施例2和实施例3中的颗粒分别进行治疗,一日2次,连服2个月。
统计结果如下:
结果:治疗组(采用实施例1、2、3的药剂组)中90例患者中显效占49例,占54%;好转37例,占41%,总体显效与好转为95%。
从上表可以看出,本发明的药物组合物具有良好的降糖作用,无论是空腹血糖还是餐后血糖,均有明显的改善;并且,本发明所涉及的组合物对于缓解口渴、饥饿、疲劳、多尿等临床症状有显著的改善作用,对改善患者的生活质量非常有效。
Claims (3)
1.一种预防及治疗糖尿病的中药片剂,其特征在于:按照重量份数计,由以下中药原料配制:生地10-15份,葛根8-10份,黄连8-10份,麦冬4-8份,人参10-15份,牛膝5-8份,知母5-8份,山栀子5-8份,怀山药10-15份,牡丹皮6-8份,泽泻6-8份,茯苓8-10份,益智仁10-15份,炙甘草10-15份,五味子10-15份。
2.根据权利要求1所述的一种预防及治疗糖尿病的中药片剂,其特征在于:按照重量份数计,由以下中药原料配制而成:生地12份,葛根9份,黄连9份,麦冬5份,人参12份,牛膝7份,知母6份,山栀子7份,怀山药12份,牡丹皮7份,泽泻7份,茯苓9份,益智仁13份,炙甘草13份,五味子13份。
3.一种权利要求1所述的预防及治疗糖尿病的中药片剂的制备方法,其特征在于,步骤如下:将除人参和怀山药之外的其他原料放入蒸馏瓶中,用水蒸气蒸馏法提取其有效成分,将人参和怀山药粉碎成细粉后,与蔗糖粉混合放入提取液中,搅拌均匀制成软材,过10-20目筛得到颗粒,将颗粒加入硬脂酸镁润滑剂后,放入压片机压片,得到每片0.15-0.18g的片剂即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410583041.8A CN104367912A (zh) | 2014-10-27 | 2014-10-27 | 一种预防及治疗糖尿病的中药及其片剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410583041.8A CN104367912A (zh) | 2014-10-27 | 2014-10-27 | 一种预防及治疗糖尿病的中药及其片剂的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104367912A true CN104367912A (zh) | 2015-02-25 |
Family
ID=52547272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410583041.8A Pending CN104367912A (zh) | 2014-10-27 | 2014-10-27 | 一种预防及治疗糖尿病的中药及其片剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104367912A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1103305A (zh) * | 1993-11-27 | 1995-06-07 | 李南山 | 消渴散及其配制方法 |
CN103599381A (zh) * | 2013-10-23 | 2014-02-26 | 陈维娜 | 治疗糖尿病的中药 |
CN104042909A (zh) * | 2014-06-28 | 2014-09-17 | 张璟璟 | 一种治疗糖尿病的药物 |
-
2014
- 2014-10-27 CN CN201410583041.8A patent/CN104367912A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1103305A (zh) * | 1993-11-27 | 1995-06-07 | 李南山 | 消渴散及其配制方法 |
CN103599381A (zh) * | 2013-10-23 | 2014-02-26 | 陈维娜 | 治疗糖尿病的中药 |
CN104042909A (zh) * | 2014-06-28 | 2014-09-17 | 张璟璟 | 一种治疗糖尿病的药物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100435831C (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN105920514A (zh) | 治疗代谢综合征的中药组合物 | |
CN102205108B (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
CN101954006B (zh) | 治疗失眠的中药 | |
CN105031517A (zh) | 一种降三高的铁皮石斛保健茶及其制备方法 | |
CN102813870B (zh) | 一种治疗酒精中毒痛风的中药复方制剂及制备方法与应用 | |
CN102319341B (zh) | 一种治疗和预防糖尿病的中药复方 | |
CN103623280B (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN104083640A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN104367753A (zh) | 一种治疗2型糖尿病的中药组合物 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN102935214B (zh) | 一种治疗尿毒症的中药组合物 | |
CN1192789C (zh) | 一种治疗糖尿病的茶及其制备方法 | |
CN104510937A (zh) | 一种治疗小儿哮喘的中药配方及其膏方的制备方法 | |
CN104367912A (zh) | 一种预防及治疗糖尿病的中药及其片剂的制备方法 | |
CN103356870A (zh) | 一种治疗产后缺乳的中药制剂及制备方法 | |
CN107913389A (zh) | 一种治疗甲状腺肿大的中药组合物及其制备方法 | |
CN106902250A (zh) | 一种中西医联合治疗糖尿病的复方药物 | |
CN106166251A (zh) | 一种用于治疗哮喘的中药制剂及其制备方法 | |
CN105943860A (zh) | 一种用于治疗糖尿病的药物制剂及其制备方法 | |
CN105727243A (zh) | 一种治疗心肌炎的中药组合物及其制备方法 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN105920409A (zh) | 一种用于治疗阿尔茨海默病的药物制剂及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150225 |
|
RJ01 | Rejection of invention patent application after publication |